These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5631892)

  • 1. [Etiopathogenesis of thyrotoxicosis].
    de Medeiros Neto GA
    Rev Paul Med; 1967 Jan; 70(1):48-52. PubMed ID: 5631892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiology of hyperthyroidism].
    Lemarchand-Béraud T; Vannotti A; Griessen M
    Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etiopathogenic forms of thyrotoxicosis].
    Conde Yagüe R; Miró Jornet J; Ostolaza Osa JM; Moscoso del Prado J
    Rev Clin Esp; 1982 Dec; 167(5):279-86. PubMed ID: 6762626
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 6. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
    Strumia E
    Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal thyrotoxicosis with long acting thyroid stimulator-protector.
    O'Hearlihy C
    Ir Med J; 1977 Mar; 70(4):124-5. PubMed ID: 576864
    [No Abstract]   [Full Text] [Related]  

  • 8. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
    McKenzie JM
    Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 10. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
    Studer H
    Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyroid stimulating substances in human saliva.
    Sahadevan V; Field EO
    Strahlentherapie Sonderb; 1968; 67():425-35. PubMed ID: 4180681
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial incidence of long-acting thyroid stimulator (LATS) in Graves' disease.
    Bonnyns M; Vanhaelst L
    Horm Metab Res; 1972 Mar; 4(2):132. PubMed ID: 5067566
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of Graves' disease and endocrine exophthalmos.
    Anderson DR
    Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-acting thyroid stimulator and thyroid disease.
    Kriss JP
    Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
    [No Abstract]   [Full Text] [Related]  

  • 17. Current concepts concerning the pathogenesis of the hyperthyroidism of Graves' disease.
    Orth DN
    J Tenn Med Assoc; 1967 Jan; 60(1):41-7. PubMed ID: 5343003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperthyroidism and thyroid carcinoma (paraneoplastic syndrome?)].
    Hartemann P; Leclere J
    Rev Fr Endocrinol Clin; 1972; 13(2):157-68. PubMed ID: 4661130
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
    Földes J; Gesztesi E; Takács I
    Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathogenesis of hyperthyroidism.
    McKenzie JM
    Triangle; 1969; 9(1):2-8. PubMed ID: 5820145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.